Neglected tropical diseases

PCT databank

Lymphatic filariasis

Lymphatic filariasis situational analyses, core implementation data and trend data are provided through direct access to the interactive reports.

View interactive report on status of distribution and implementation

This query will show a table with countries in rows and indicators in columns. You can filter this table by region, country and year.

Latest update – 14 November 2017.


Hold down "Ctrl" key to select several countries

Source: Global Programme to Eliminate Lymphatic Filariasis

PC - Preventive Chemotherapy
MDA - Mass Drug Administration
IU - Implementation Unit
IVM - Ivermectin
ALB - Albendazole
DEC - Diethylcarbamazine citrate
DS - DEC-fortified salt

Proportion of global population requiring preventive chemotherapy for lymphatic filariasis (%) – proportion (%) of the population requiring PC for LF in the country out of population requiring PC for LF globally.
Population requiring PC for LF - total population living in all the endemic IUs and which require preventive chemotherapy (PC).
Geographical coverage - proportion (%) of endemic IUs covered by MDA.
Programme (drug) coverage - proportion (%) of individuals treated as per programme target (Total population of targeted IUs).
National coverage - proportion (%) of the population requiring PC for LF in the country that have been treated.

Disclaimer: Unless otherwise specified, the preventive chemotherapy database reports information as provided by countries through World Health Organization reporting processes. All reasonable precautions have been taken to verify the information contained in this publication. In no event shall the World Health Organization be liable for damages arising from its use.